MATINAS BIOPHARMA HLDGS INC's ticker is MTNB and the CUSIP is 576810105. A total of 72 filers reported holding MATINAS BIOPHARMA HLDGS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $395 | -63.9% | 3,040 | 0.0% | 0.00% | – |
| Q2 2023 | $1,094 | -23.4% | 3,040 | 0.0% | 0.00% | – |
| Q1 2023 | $1,429 | -6.0% | 3,040 | 0.0% | 0.00% | – |
| Q4 2022 | $1,520 | -24.0% | 3,040 | 0.0% | 0.00% | – |
| Q3 2022 | $2,000 | 0.0% | 3,040 | 0.0% | 0.00% | – |
| Q2 2022 | $2,000 | 0.0% | 3,040 | 0.0% | 0.00% | – |
| Q1 2022 | $2,000 | -33.3% | 3,040 | 0.0% | 0.00% | – |
| Q4 2021 | $3,000 | -25.0% | 3,040 | 0.0% | 0.00% | – |
| Q3 2021 | $4,000 | +100.0% | 3,040 | 0.0% | 0.00% | – |
| Q2 2021 | $2,000 | -100.0% | 3,040 | -50.0% | 0.00% | – |
| Q1 2021 | $6,384,000 | +159500.0% | 6,080 | +100.0% | 0.00% | – |
| Q4 2020 | $4,000 | +100.0% | 3,040 | 0.0% | 0.00% | – |
| Q3 2020 | $2,000 | 0.0% | 3,040 | 0.0% | 0.00% | – |
| Q2 2020 | $2,000 | +100.0% | 3,040 | 0.0% | 0.00% | – |
| Q1 2020 | $1,000 | – | 3,040 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sargent Investment Group, LLC | 1,429,532 | $1,944,000 | 0.61% |
| Boxer Capital, LLC | 11,478,634 | $15,611,000 | 0.50% |
| Vivo Capital, LLC | 6,451,612 | $8,774,000 | 0.39% |
| Philadelphia Financial Management of San Francisco, LLC | 740,861 | $1,008,000 | 0.26% |
| DCF Advisers, LLC | 305,299 | $415,000 | 0.17% |
| Main Street Financial Solutions, LLC | 400,826 | $545,000 | 0.11% |
| Platform Technology Partners | 158,660 | $216,000 | 0.10% |
| STALEY CAPITAL ADVISERS INC | 600,000 | $816,000 | 0.05% |
| MONECO Advisors, LLC | 50,000 | $81,000 | 0.04% |
| CCG WEALTH MANAGEMENT, LLC | 30,000 | $41,000 | 0.04% |